| Primary |
| Type 1 Diabetes Mellitus |
19.8% |
| Drug Use For Unknown Indication |
16.2% |
| Diabetes Mellitus |
11.9% |
| Type 2 Diabetes Mellitus |
11.9% |
| Product Used For Unknown Indication |
4.3% |
| Gestational Diabetes |
4.0% |
| Lipids Increased |
4.0% |
| Hypertension |
3.6% |
| Myocardial Ischaemia |
3.6% |
| Diabetes Mellitus Insulin-dependent |
2.4% |
| Ear Infection |
2.4% |
| Nausea |
2.4% |
| Hypercholesterolaemia |
2.0% |
| Insulin-requiring Type Ii Diabetes Mellitus |
2.0% |
| Neuropathy Peripheral |
2.0% |
| Osteoporosis |
2.0% |
| Transient Ischaemic Attack |
2.0% |
| Insulin-requiring Type 2 Diabetes Mellitus |
1.6% |
| Blood Pressure |
1.2% |
| Helicobacter Gastritis |
1.2% |
|
| Blood Glucose Increased |
10.3% |
| Cerebrovascular Accident |
10.3% |
| Malaise |
7.4% |
| Pneumonia |
7.4% |
| Hypoglycaemia |
5.9% |
| Lipoatrophy |
5.9% |
| Tachycardia |
5.9% |
| Dyspnoea |
4.4% |
| Facial Palsy |
4.4% |
| Hypoaesthesia |
4.4% |
| Loss Of Consciousness |
4.4% |
| Palpitations |
4.4% |
| Pneumonia Viral |
4.4% |
| Asthenia |
2.9% |
| Blood Ketone Body |
2.9% |
| Cellulitis |
2.9% |
| Chest Pain |
2.9% |
| Expired Drug Administered |
2.9% |
| Gamma-glutamyltransferase Increased |
2.9% |
| Hypoglycaemic Unconsciousness |
2.9% |
|
| Secondary |
| Drug Use For Unknown Indication |
17.1% |
| Type 1 Diabetes Mellitus |
16.8% |
| Type 2 Diabetes Mellitus |
16.0% |
| Diabetes Mellitus Insulin-dependent |
13.9% |
| Product Used For Unknown Indication |
12.0% |
| Diabetes Mellitus |
6.5% |
| Hypertension |
5.4% |
| Myocardial Ischaemia |
4.9% |
| Hypercholesterolaemia |
1.6% |
| Insulin-requiring Type Ii Diabetes Mellitus |
1.6% |
| Smoking Cessation Therapy |
1.4% |
| Abdominal Discomfort |
0.5% |
| Blood Cholesterol Abnormal |
0.5% |
| Gestational Diabetes |
0.5% |
| Hypothyroidism |
0.5% |
| Prophylaxis |
0.5% |
|
| Influenza Like Illness |
14.3% |
| Malaise |
14.3% |
| Blood Glucose Increased |
10.0% |
| Road Traffic Accident |
7.1% |
| Sedation |
7.1% |
| Blood Count Abnormal |
4.3% |
| Hypoglycaemia |
4.3% |
| Idiopathic Thrombocytopenic Purpura |
4.3% |
| Oedema |
4.3% |
| Premature Baby |
4.3% |
| Diabetes Mellitus Inadequate Control |
2.9% |
| Diabetic Ketoacidosis |
2.9% |
| Head Injury |
2.9% |
| Hypertension |
2.9% |
| Incorrect Storage Of Drug |
2.9% |
| Palpitations |
2.9% |
| Precursor B-lymphoblastic Lymphoma |
2.9% |
| Renal Mass |
2.9% |
| Blood Glucose Decreased |
1.4% |
| Cholelithiasis |
1.4% |
|
| Concomitant |
| Insulin-requiring Type Ii Diabetes Mellitus |
26.5% |
| Diabetes Mellitus Insulin-dependent |
14.5% |
| Type 1 Diabetes Mellitus |
14.5% |
| Type 2 Diabetes Mellitus |
10.8% |
| Drug Use For Unknown Indication |
8.4% |
| Diabetes Mellitus |
7.2% |
| Hypertension |
3.6% |
| Juvenile Idiopathic Arthritis |
2.4% |
| Liver Disorder |
2.4% |
| Neuralgia |
2.4% |
| Osteoporosis Prophylaxis |
2.4% |
| Asthma |
1.2% |
| Hypothyroidism |
1.2% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.2% |
| Seasonal Allergy |
1.2% |
|
| Respiratory Tract Infection |
12.9% |
| Coronary Artery Bypass |
9.7% |
| Restlessness |
9.7% |
| Neonatal Infection |
6.5% |
| Palpitations |
6.5% |
| Speech Disorder |
6.5% |
| Vomiting |
6.5% |
| Head Injury |
3.2% |
| Injection Site Infection |
3.2% |
| Injection Site Necrosis |
3.2% |
| Intestinal Obstruction |
3.2% |
| Myocardial Infarction |
3.2% |
| Necrobiosis |
3.2% |
| Paranoia |
3.2% |
| Pharmaceutical Product Complaint |
3.2% |
| Road Traffic Accident |
3.2% |
| Shock Hypoglycaemic |
3.2% |
| Stillbirth |
3.2% |
| Swelling Face |
3.2% |
| Tachycardia |
3.2% |
|
| Interacting |
| Type 1 Diabetes Mellitus |
66.7% |
| Hypercholesterolaemia |
33.3% |
|
| Loss Of Consciousness |
100.0% |
|
